Click here to find out the fastest and easiest way to use Shop.com:
Tuesday, November 19, 2013
Wednesday, November 13, 2013
Did you know a vitamin D deficiency more than DOUBLES your risk of type II diabetes?
Just a few years ago, vitamin D was simply known as the
“bone vitamin.” Thanks to the hard work of many scientists, especially Michael
Holick, MD, a pioneer in vitamin D research, the data show that nearly every
tissue and cell type in the body has receptors for vitamin D. As a result of
this discovery, much higher doses are required for optimal functioning. This
discovery has radically changed how we understand the role of vitamin D in the
body.
Unless you
body is at optimal levels, you are opening the door to a host of disorders,
ranging from heart disease and Alzheimer’s to weak bodes and diabetes.
In fact,
even if you have normal blood sugar today, a vitamin D deficiency makes you 91%
more likely to progress to insulin resistance, or “pre-diabetes,” and it more
than doubles your risk from progressing to active, type II diabetes.
Unfortunately,
vitamin D deficiency is a global epidemic. An estimated 1 billion people do not
have adequate vitamin D levels. And 64% of Americans don’t have enough vitamin
D to keep all of their tissues operating at peak capacity.
The results
of this deficiency are catastrophic. Studies have now shown that vitamin D
deficiency is associated with increased risk of a long list of diseases that
span all systems of the body. In fact, low levels of vitamin D increase the
risk of non-Alzheimer’s dementia almost 20 times!
While
checking for vitamin D levels is still not standard care for many physicians,
you will realize from reading this article that assessing vitamin D status is
one of the most important health protecting steps you can take. Fortunately,
achieving optimal levels of vitamin D is easy, inexpensive, and highly
protective against a range of lethal diseases.
Tuesday, November 12, 2013
Critically Ill Have Reduced Levels of CoQ10
An article
published in the Journal of Critical Care revealed lower levels of
coenzyme Q10 (CoQ10) in critically ill patients in comparison with healthy
men and women.*
The study
compared 36 adult intensive care unit patients with 18 healthy controls.
Septic shock was present in 12 of the critically ill subjects. While the
lowest levels of plasma CoQ10 occurred in septic shock patients, levels were
lower in critically ill patients both with and without septic shock in
comparison with healthy subjects. Reduced levels of CoQ10 were also
associated with increased age and with a decline in the ability to perform
activities of daily living after hospital discharge. Authors Andrea Coppadoro
and colleagues remark that CoQ10 supplementation has been associated with
improvement in activities of daily living scores, neuromuscular function, and
other long-term outcomes in certain groups, suggesting that supplementation
could also benefit the outcome of the critically ill.
—D. Dye
|
Reference
|
* J Crit Care. 2013 Apr 22.
To purchase, CLICK HERE: http://isotonix.marketamerica.com/knapp/USA/Search/Product/2250
|
High Homocysteine, Low Folate, and B12 Predict Macular Degeneration
An article
published in the American Journal of Clinical Nutrition reports the
finding of a protective effect for higher levels of vitamin B12 and folate
against the risk of developing age-related macular degeneration (AMD).* The
study also revealed a greater risk of AMD in association with higher levels
of homocysteine.
Paul
Mitchell and his colleagues analyzed data from 1,390 participants in the Blue
Mountains Eye Study of common eye diseases. Eye examinations were conducted
upon enrollment and at five, ten, and fifteen years. Serum homocysteine,
folate, and vitamin B12 levels were measured and dietary questionnaires were
completed at the five-year follow-up visit.
From the
five-year through the fifteen-year follow-up visit, 219 subjects were
diagnosed with AMD. In comparison with those with lower homocysteine levels,
participants whose levels were greater than 15 micromoles per liter had an up
to 56% greater risk of AMD.
Editor’s Note: Among those
with deficient folate levels, the risk of AMD was up to 89% higher in
comparison with the risk experienced by subjects with greater levels. Vitamin
B12 deficiency also increased risk.
—D. Dye
|
Reference
To purchase click here: http://isotonix.marketamerica.com/knapp/USA/Search/Product/2241
|
Monday, November 11, 2013
In Related News: Vitamin D May Protect Against the Development of Uterine Fibroids
A recent issue of Epidemiology published an
article that reports the finding of vitamin D researcher Bruce W. Hollis and
his colleagues of a lower risk of uterine fibroid tumors in women with
sufficient levels of vitamin D.*
The study evaluated 620 African American women and 416
Caucasian women between the ages of 35 to 49 who were enrolled in the
National Institute of Environmental Health Sciences Uterine Fibroid Study.
Serum 25-hydroxyvitamin D levels were measured in blood samples collected
upon enrollment, and ultrasound examinations ascertained the presence and
size of fibroids.
Subjects with sufficient serum levels of the vitamin,
which the researchers classified as 20 ng/mL or higher, had a 32%
lower risk of having fibroids in comparison with those whose levels were
sufficient. Each 10 ng/mL increase in vitamin D was associated with a 20%
reduction in fibroid risk.
—D. Dye
|
Reference
|
* Epidemiology. 2013 May;24(3):447-53.
|
Thursday, November 7, 2013
Study Results Indicate Benefits of Antioxidants Following Breast Cancer Therapy
In honor of breast cancer awareness month, for anyone you
know who has breast cancer, the risk of breast cancer recurrence was 36% lower
in association with the use of Vitamin D.
An article published in Breast Cancer Research and
Treatment reports that supplementation with antioxidants after treatment
for breast cancer is not only safe, but may help improve survival.*
Elizabeth M. Poole of Harvard University and her associates
analyzed data from 12,019 breast cancer survivors enrolled in one of four
studies included in the After Breast Cancer Pooling Project. The analysis
examined the use of supplements at least one year after diagnosis. Over
follow-up, 1,298 deaths occurred, of which 65% were due to breast
cancer.
Sixty percent of the women reported using supplements from
one-to-five years following diagnosis. The use of any antioxidant supplement,
categorized as vitamins C, E, or a multivitamin supplement in this study, was associated
with a 16% lower adjusted risk of dying from any cause over follow-up,
and for those who used all three supplements, the risk was 21% lower.
The risk of breast cancer recurrence was 36% lower
in association with the use of vitamin D among women with estrogen
receptor-positive tumors.
—D. Dye
To buy this product, CLICK HERE:
http://isotonix.marketamerica.com/knapps/USA/Search/Product/13324
Reference: *Breast Cancer Res Treat, 2013 May 10
Tuesday, October 29, 2013
Did you know that high blood sugar increases the negative effects of cholesterol?
According to Life Extension Magazine:
In order to reduce risk, there must be a systematic approach and understanding of the multiple factors of cardiovascular risk and atherosclerosis. Optimal cholesterol management is important for risk reduction, but so are the multiple risk factors that Life Extension has long identified. Accordingly, efforts to lower cholesterol to mitigate cardiovascular risk will only be met with optimal success if paired with measures to reduce other risk factors such as inflammation, oxidation, hypertension, excess plasma glucose, excess body weight, fibrinogen, excess homocysteine, low vitamin K, insufficient vitamin D, hormone imbalance; etc. Mainstream medicine is quick to point out that 10-15% of patients with coronary heart disease have no apparent major risk factors
The 17 Daggers of Arterial Disease graphic has been published in Life Extension Magazine and illustrates the risk factors that Life Extension has identified as being critical to address in order to maintain optimal vascular health.
The chart below is the traditional cholesterol testing versus the much more informative VAP cholesterol test. Be sure to ask your doctor for the VAP test.
VERTICAL AUTO PROFILE (VAP)
CLASSIC LIPID PANEL
Directly measures LDL
{more accurate assessment of LDL and therefore more prognostic of risk for heart disease}Estimates LDL using a calculation
Calculated levels lose accuracy when triglycerides are very high (> 400 mg/dL)Measures ApoB-100, which is a direct indication of LDL particle number {more particles are associated with higher atherogenic risk} Not included Measures Lp(a)
{some evidence suggests that Lp(a) is more atherogenic than LDL}Not included Identifies LDL density pattern
{a small, dense pattern is more atherogenic (Pattern B); a large buoyant pattern is less atherogenic (Pattern A)}Not included Specifies lipoprotein subclass levels
{some subclasses of lipoproteins are more atherogenic than others}
Using these 2 all natural products will significantly improve your cardiovascular health.
This all natural product supports healthy cholesterol, blood pressure, circulation, and nitric oxide levels. No pills to swallow! Click here:
This natural product counteracts the effects of elevated blood sugar:
Link to full article: http://www.lef.org/protocols/heart_circulatory/cholesterol_management_01.htm
Tuesday, October 8, 2013
Dr. Oz recommends this natural substance to have younger looking skin and body!
Click here to see what he has to say:
For
the worlds most bioavailable Pynogenol click here:
Monday, October 7, 2013
Shocking X-Ray Photo of Undigested Vitamins!
Nauseous from your vitamins? Not feeling the benefits? That’s because pills have binders and fillers! Look at this x-ray taken by a doctor showing 3 days worth of undigested pills!
Click here for some of my favorite products:http://w.explorema.com/KatherineKnappMarketing/myfavoriteproducts.jsp
Hot flashes? Night sweats heart palpitations? Research shows this product will help you!
GENEVA, Switzerland – A clinical trial published in this month’s The
Journal of Reproductive Medicine found that natural supplement Pycnogenol®
(pic-noj-en-all), an antioxidant plant extract from the bark of the French
maritime pine tree, minimizes climacteric symptoms of menopausal women.
Perimenopause, the transition that women experience leading into menopause,
lasts an average of four years and is marked by a number of uncomfortable
symptoms including hot flashes, insomnia, night-time sweating, palpitations,
depression, anxiety and memory problems.
“Since climacteric symptoms vary from woman to woman and can manifest as
any number of discomforts, it is often a difficult condition to effectively
treat. We found that Pycnogenol® can aid in relief of a number
of these symptoms, which helps improve the quality of women’s life during this
transitional period,” said Takafumi Kohama, lead researcher from Keiju Medical
Center.
The study was
conducted at Keiju Medical Center in Ishikawa Prefecture, Japan and examined
170 perimenopausal women. A randomized, placebo-controlled, double-blind,
parallel-group clinical trial was conducted and participants were given either
placebo capsules or 30 mg of Pycnogenol® twice per day, over a
period of 12 weeks.
The rationale of the study was to
identify menopausal symptoms which respond particularly well to supplementation
with a low dosage of Pycnogenol®. Dr. Kohama and his group
discovered that Pycnogenol® is most effective for lowering hot
flashes and nighttime sweating. Kohama
explains that thermal dysregulation may relate to the inability of menopausal
women to radiate off excess heat because peripheral blood vessels
insufficiently expand. Pycnogenol® supports vascular
relaxation, which allows the body to rid of excess body heat, subsiding the
sensation of hot flashes and nighttime sweating. Dr. Kohama also emphasizes the
increased general risk for cardiovascular health problems of menopausal women,
which may benefit from the improved vascular function with Pycnogenol®.
The discovery of lowered
heart palpitations in women taking Pycnogenol® in this study
provides further support to this point.
This study
systematically investigated and compared hormonal changes of women taking
Pycnogenol® or placebo. Kohama and his co-workers did not find
any significant changes between groups as for estradiol (E2), follicle
stimulating hormone (FSH), insulin-like growth factor (IGF), IGF binding
protein 3 (IGFBP-3) and dehydroepiandrosterone. The evidence for non-hormonal
effects of Pycnogenol® may be welcomed by women who wish to
soothe menopausal symptoms without using supplements containing soy, kudzu, red
clover and other herbals to exert hormonal activity.Though some women dropped out of the study, none of them left the study
because of unwanted effects related to treatment.
An additional
questionnaire, the Kupperman index, was given to participants to describe and
score the level of discomfort related to climacteric symptoms, using values
ranging from one (heavy discomfort) to four (no discomfort). Differences in
baseline performance between the placebo group and Pycnogenol® group were
tested as well as a comparison of perimenopausal symptom scores obtained during
treatment. According to the study, the total symptom improvement using the Kupperman
index, which represents the most commonly utilized questionnaire in Japan, was
statistically significant versus the placebo group. The study identified a
number of further menopausal symptom improvements such as decreased heart
palpitations which reached borderline statistical significance.
“These findings leave little doubt about the benefit of Pycnogenol® for
women interested in controlling climacteric symptoms with a more natural
approach. Our study is the first to provide evidence for the safety and
efficacy of Pycnogenol® in perimenopausal women,” said Kohama.
This
study confirms findings from two previous studies, one of which investigated
200 menopausal women in double-blind, placebo-controlled fashion for half a
year, that Pycnogenol®
effectively improves menopausal signs and symptoms. Furthermore, Pycnogenol®’s
ability to support heart health is of particular significance as menopausal
women live at elevated risk for cardiovascular disease.
For
the worlds most bioavailable Pycnogenol click here: http://isotonix.marketamerica.com/knapps/USA/Search/Product/2217
About Pycnogenol®
Pycnogenol® is a natural
plant extract originating from the bark of the maritime pine that grows along
the coast of southwest France and is found to contain a unique combination of
procyanidins, bioflavonoids and organic acids, which offer extensive natural
health benefits. The extract has been widely studied for the past 40
years and has more than 280 published studies and review articles ensuring
safety and efficacy as an ingredient. Today, Pycnogenol® is available in more than 700 dietary
supplements, multi-vitamins and health products worldwide. For more
information, visit www.pycnogenol.com.
About Horphag ResearchHorphag Research Ltd. is the
exclusive worldwide supplier of Pycnogenol® (pic-noj-en-all) French maritime
pine bark extract. Pycnogenol® is a registered trademark of Horphag Research
Ltd.; Guernsey and the company is the recipient of the 2008 Frost &
Sullivan North American Health Ingredients Excellence in Research Award. For
more information about Pycnogenol® visit our Web site at www.pycnogenol.com
Subscribe to:
Posts (Atom)